Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours-Reference-Cited by-同舟云学术

Phase II study of temozolomide plus pegylated liposomal doxorubicin in the treatment of brain metastases from solid tumours

Published:2005-07-12 Issue:1 Volume:57 Page:34-39
ISSN:0344-5704
Container-title:Cancer Chemotherapy and Pharmacology
language:en
Short-container-title:Cancer Chemother Pharmacol

Author:

Caraglia Michele,Addeo Raffaele,Costanzo Raffaele,Montella Liliana,Faiola Vincenzo,Marra Monica,Abbruzzese Alberto,Palmieri Giovannella,Budillon Alfredo,Grillone Francesco,Venuta Salvatore,Tagliaferri Pierosandro,Prete Salvatore Del

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology

Link

http://link.springer.com/content/pdf/10.1007/s00280-005-0001-z.pdf

Reference29 articles.

1. Abrey LE, Christodoulou C (2001) Temozolomide for treating brain metastases. Semin Oncol 28:34–42

2. Awada A, Gil T, Sales F, Dubuisson M, Verecken P, Klastersky J, Moerman C, de Valeriola D, Piccart MJ (2004) prolonged schedule of temozolomide (Temodal) plus liposomal doxorubicin (Caelyx) in advanced solid cancers. Anticancer Drugs 15:499–502

3. Berk L (1995) An overview of radiotherapy trials for the treatment of brain metastases. Oncology 9:1205–1219

4. Bleehen NM, Newlands ES, Lee SM, Thatcher N, Selby P, Calvert AH, Rustin GJ, Brampton M, Stevens MF (1995) Cancer research campaign phase II trial of temozolomide in metastatic melanoma. J Clin Oncol 13:910–913

5. Bower M, Newlands ES, Bleehen NM, Brada M, Begent RJ, Calvert H, Colquhoun I, Lewis P, Brampton MH (1997) Multicentre CRC phase II trial of temozolomide in recurrent or progressive high-grade glioma. Cancer Chemother Pharmacol 40:484–488

Cited by 62 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted opening of the blood-brain barrier using VCAM-1 functionalised microbubbles and “whole brain” ultrasound;Theranostics;2024

2. Revisiting Temozolomide's role in solid tumors: Old is gold?;Journal of Cancer;2024

3. Next Generation of Brain Cancer Nanomedicines to Overcome the Blood–Brain Barrier (BBB): Insights on Transcytosis, Perivascular Tumor Growth, and BBB Models;Advanced Therapeutics;2023-09-24

4. Therapeutic performance of temozolomide-loaded nanomaterials: A state-of-the-art;Journal of Drug Delivery Science and Technology;2023-08

5. Metastatic Breast Cancer: Review of Emerging Nanotherapeutics;Cancers;2023-05-25